28 /100
MEDIUM RISK
Score updated Jul 13, 2026

BLND — Blend Labs, Inc. Dilution Risk Tracker

Track BLND dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLND — Get alerts when the score changes →

As of July 13, 2026, Blend Labs, Inc. (BLND) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Blend Labs, Inc. has a market capitalization of $433.39M, 247.34M shares outstanding, 195 institutional holders tracked. Key dilution vectors include approximately 31 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.57 approaching $1 threshold
🔔 Track BLND — Get forecast alerts →

💹 Market Data

Market Cap$433.39M
Shares Outstanding247.34M
Float175.27M
Cash$59.04M
Debt$1.36M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.3% shares (2026Q1 vs prior)
195 institutional holders · 176.37M shares
#1 LIGHTSPEED MANAGEMENT COMPANY, L.L.C. 23.13M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 19.30M shares
#3 BlackRock, Inc. 16.29M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest13.02M
Days to Cover4.2
% of Float7.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 24, 2026
4 INSIDER TRANSACTION Feb 24, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BLND Shareholders

Blend Labs, Inc. (BLND) has a DilutionScore of 28/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BLND shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BLND in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BLND alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BLND Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BLND — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BLND
📊 BLND FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BLND Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.